Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.
Ohmori H, Nakamura M, Kada A, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Okumura A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Kawasaki M, Sano N, Akaboshi S, Tanuma N, Sone S, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T. Ohmori H, et al. Among authors: koretsune y. Kurume Med J. 2018 Dec 21;65(1):11-16. doi: 10.2739/kurumemedj.MS651003. Epub 2018 Aug 30. Kurume Med J. 2018. PMID: 30158356 Free article.
Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus Edoxaban.
Ohmori H, Kada A, Nakamura M, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Mizukami A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Sano N, Tanuma N, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T. Ohmori H, et al. Among authors: koretsune y. Ann Vasc Dis. 2019 Sep 25;12(3):372-378. doi: 10.3400/avd.oa.19-00040. Ann Vasc Dis. 2019. PMID: 31636749 Free PMC article.
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design.
De Caterina R, Agnelli G, Laeis P, Unverdorben M, Rauer H, Wang CC, Nakamura M, Chiu KM, Reimitz PE, Koretsune Y, Chen C, Thee U, Kaburagi J, Kim YH, Choi WI, Yamashita T, Cohen A, Kirchhof P. De Caterina R, et al. Among authors: koretsune y. Clin Cardiol. 2019 Dec;42(12):1147-1154. doi: 10.1002/clc.23279. Epub 2019 Oct 25. Clin Cardiol. 2019. PMID: 31650560 Free PMC article.
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, Akishita M, Lip GYH, Yamashita T; ELDERCARE-AF Committees and Investigators. Okumura K, et al. N Engl J Med. 2020 Oct 29;383(18):1735-1745. doi: 10.1056/NEJMoa2012883. Epub 2020 Aug 30. N Engl J Med. 2020. PMID: 32865374 Clinical Trial.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. Among authors: koretsune y. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Rivaroxaban vs. warfarin in Japanese patients with non-valvular atrial fibrillation in relation to age.
Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iekushi K, Yamanaka S, Tajiri M; J-ROCKET AF Study Investigators. Hori M, et al. Among authors: koretsune y. Circ J. 2014;78(6):1349-56. doi: 10.1253/circj.cj-13-1324. Epub 2014 Apr 7. Circ J. 2014. PMID: 24705469 Free article. Clinical Trial.
281 results